• Home
  • NEWS
  • News Scientifiche
  • Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China

12 Gennaio 2022

Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China

Posted in Scientific

Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China

Studies have showed that long-term sequelae from COVID-19 may affect human respiratory system, cardiovascular system, nervous system, immune system etc. with a negative impact on the patients’ mental health, well-being and quality of life, but the lungs are the organ most likely to sustain serious impairment from COVID-19.

The convalescent patients with COVID-19 have manifested particularly noticeable pulmonary diffusing capacity impairment (PDCI). However, the affecting factors for PDCI still remain undefined. 

This study evaluated PDCI of COVID-19 survivors after 18 months of recovery and its affecting factors, aiming to provide reference for treatment of the long COVID patients during the rehabilitation period.

 


Article details:

- Title: Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China
- Authors: Bo Xu, Fu-qiang Ma, Cong He, Ji-xian Zhang, Min Yang, Zuo-wei Hu.
- Published in: Journal of Infection - 05 Jan 2022
- Linkhttps://doi.org/10.1016/j.jinf.2021.12.020